Ultragenyx Pharmaceutical (RARE) FCF Payout Ratio (2014)

Ultragenyx Pharmaceutical's (RARE) quarterly FCF Payout Ratio came in at 0.4 in Q1 2014.

Ultragenyx Pharmaceutical (RARE) FCF Payout Ratio (2014) Analysis & Trends

Ultragenyx Pharmaceutical (RARE) has 1 years of FCF Payout Ratio data on file, last reported at 0.4 in Q1 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.12
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Ultragenyx Pharmaceutical	2.72 Bn	2.31 Bn	106.00 Mn	-

Download Data

Date	Value
Mar 31, 2014	-0.40